UBE2K and Hepatic fibrosis: LIG prevents and alleviates the development of liver fibrosis by downregulating TGFβ1, TβRII, CCN2, and Smad2/3, and type I collagen while upregulating Smad7 [26, 27] and inhibits proliferation of hepatic stellate cells [28].